title: Prostaglandin E2 induction of abortion and fetal demise.
abstract: Prostaglandin E2 (PGE2) suppositories have been shown to be active contractile agents and are effective in uterine evacuation for mid-trimester abortion or fetal demise. In this study, 85 patients were treated with vaginal PGE2 suppositories. When laminaria were used in patients with closed cervices, and compared to those who had minimal cervical dilatation, there was no difference in the time from induction to expulsion. Ninety-three percent of the 85 patients aborted successfully within 24 h. In each of the seven "failures", three or less suppositories were used prior to a dilatation and evacuation procedure. In this study, 81% of the abortions were complete, and in one-third of the remaining patients dilatation and curettage was performed just after delivery of the fetus. The incidence of minor side-effects ranged from 12 to 21%, and there were no major complications. It is concluded that the use of vaginal prostaglandin E2 suppositories for induction of mid-trimester abortion or fetal demise in the third trimester is safe and effective.
authors.affiliation: Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson 39216.
authors.forename: T L
authors.initials: TL
authors.lastname: Wiley
authors.forename: C P
authors.initials: CP
authors.lastname: Poole
authors.forename: K S
authors.initials: KS
authors.lastname: Gookin
authors.forename: W L
authors.initials: WL
authors.lastname: Wiser
authors.forename: J C
authors.initials: JC
authors.lastname: Morrison
mesh_terms: D000025:Abortion, Eugenic / Q000379:methods*; D000028:Abortion, Induced / Q000379:methods*; D004107:Dilatation and Curettage; D015232:Dinoprostone / Q000009:adverse effects; D005260:Female; D005313:Fetal Death; D006801:Humans; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third
chemical_list: D015232:Dinoprostone